Thermo Fisher Scientific (TMO)'s Chief Financial Officer To Retire In Early 2016

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that Peter M. Wilver, senior vice president and chief financial officer, has decided to retire, effective March 31, 2016. The company's board of directors has elected Stephen Williamson, currently vice president of financial operations, as his successor, effective August 1, 2015. Williamson will report to Marc N. Casper, president and chief executive officer of Thermo Fisher.

Suggested Articles

Californian RNA biotech Arrowhead will lose its COO and R&D head from next year but is hiring a new CMO and CSO to help steady its research exec team.

The biotech began testing the small molecule in a phase 3 trial of heavily pretreated small cell lung cancer patients late last year. 

Roche is spending up to $1.4 billion to snap up a scarring-focused biotech, nabbing an FDA breakthrough-tagged therapy in the process.